Clinical Trials on Marinesco-Sjogren Syndrome

Total 33707 results

Pontificia Universidad Catolica de Chile
Formulario MAgistral Farmacias Ahumada

Completed

A Comparison of Orally Pilocarpine and Artificial Saliva in Xerostomy Treatment

Xerostomia | Primary Sjogren | Secondary Sjogren

Chile
Akdeniz University

Completed

Pelvic Floor Exercises in Patients With Sjögren's

Sjögren Syndrome | Sjögren

Turkey
University of Nebraska

Completed

Sjogren-Larsson Syndrome: Natural History, Clinical Variation and Evaluation of Biochemical Markers (SLS)

Sjogren-Larsson Syndrome (SLS)

United States
Rise Therapeutics LLC

Not yet recruiting

R-2487 in Patients With Sjogren's Syndrome (SS) (R-2487-SS-01)

Sjogren's Syndrome | Sjögren | Sjögren Syndrome, Unspecified
Aldeyra Therapeutics, Inc.

Completed

RESET Trial - Part 1 - A Phase 3 Trial in Subjects With Sjögren-Larsson Syndrome (SLS)

Sjogren-Larsson Syndrome

United States
Novartis Pharmaceuticals

Recruiting

Two-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome (NEPTUNUS-1)

Sjogren Syndrome

United States, Belgium, Austria, Brazil, Mexico, Portugal, China, Korea, Republic of, Turkey, Spain, Chile, Poland, Germany, Guatemala, Czechia, France, Lithuania, Singapore
Novartis Pharmaceuticals

Recruiting

Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome (NEPTUNUS-2)

Sjogren Syndrome

United States, China, Germany, Lebanon, India, Spain, Hungary, Japan, Brazil, Israel, Canada, Italy, Chile, Colombia, Argentina, Greece, United Kingdom, Taiwan, Australia, Bulgaria, Mexico, South Africa, France, Romania, Poland, Slovakia, S...
Novartis Pharmaceuticals

Active, not recruiting

Biopsy Based Study to Understand Mechanism of Action of Ianalumab in Salivary Glands and Explore Relationships With Clinical Assessments.

Sjogren Syndrome

France
Novartis Pharmaceuticals

Completed

Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS)

Primary Sjogren Syndrome

United States, Belgium, Italy, Austria, Israel, France, Germany, Hungary, Netherlands, United Kingdom, Japan, Portugal, Argentina, Spain, Taiwan, Russian Federation, Romania, Chile, Poland
Aldeyra Therapeutics, Inc.

Completed

A Study of Topical NS2 Cream to Treat Ichthyosis in Sjögren-Larsson Syndrome (SLS)

Sjögren-Larsson Syndrome

United States
Federal University of São Paulo
Allergan

Completed

Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease

Evaporative Dry Eye Disease | Primary Sjogren Syndrome | Secondary Sjogren Syndrome | Aqueous Deficient Dry Eye Disease

Brazil
University Hospital, Brest

Completed

Ultrasound Elastography of Salivary Glands (ELSA)

sjögren Disease

France
University of Roma La Sapienza

Unknown

Cross-sectional Study of Use of Speckle Method in Early Diagnosis of Cardiovascular Dysfunction (SPEEDCARS)

Sjogren Syndrome

Italy
University of Sao Paulo General Hospital

Active, not recruiting

N-acetylcysteine for Primary Sjögren's Syndrome (NACSS)

Sicca Syndrome | Sjögren Syndrome

Brazil
Novartis Pharmaceuticals

Terminated

A Study to Evaluate the Safety, Tolerability and Efficacy of MHV370 in Participants With Sjogren's Syndrome (SjS) or Mixed Connective Tissue Disease (MCTD)

Sjogren Syndrome | Mixed Connective Tissue Disease

Spain, Hungary, Germany, China, Poland, Taiwan
Augusta University
GlaxoSmithKline

Completed

Green Tea Lozenges for the Management of Dry Mouth

Xerostomia | Sjogren Syndrome | Dry Mouth

United States
Novartis Pharmaceuticals

Recruiting

A Randomized, Double-blind 2-arm NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome. (NEPTUNUS-Ext)

Sjogrens Syndrome

Spain, Austria, Japan, Poland, Germany, Hungary, Israel, Italy, France, Portugal, Taiwan, Australia, Slovakia, United Kingdom, Guatemala, Czechia, Bulgaria, Brazil, United States, Canada, Argentina, Romania
Assistance Publique - Hôpitaux de Paris

Recruiting

Dental and Periodontal Status of Patients With Sjögren's Syndrome. (CB-SJO)

Sjögren Syndrome

France
Jiangsu Simcere Pharmaceutical Co., Ltd.

Recruiting

A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome.

Primary Sjögren Syndrome

China
University of Copenhagen
Rigshospitalet, Denmark; ITI Foundation; Gigtforeningen

Completed

Prognosis of Dental Implants in Patients With Primary Sjögren's Syndrome

Dental Implant | Primary Sjögren Syndrome
Novartis Pharmaceuticals

Completed

Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjogren's Syndrome (TWINSS)

Sjögren Syndrome

United States, United Kingdom, Netherlands, Australia, Austria, Israel, France, Germany, Greece, Hungary, Italy, Korea, Republic of, Japan, Portugal, Russian Federation, Turkey, Canada, Colombia, Romania, Argentina, Chile, Brazil, S...
University of Rochester

Completed

Pilot Trial of Ustekinumab for Primary Sjögren's Syndrome

Primary Sjögren Syndrome

United States
University Hospital, Limoges

Completed

Neurotrophins Implications in Primary Sjögren Syndrome (Neuro-SGSp)

Primary Sjögren Syndrome

France
Meir Medical Center

Unknown

the Effect of HCG Treatment as a Cardiovascular Disease Morbidity Factor in Sjogren Syndrome Patients (HAS)

Primary Sjogren Syndrome With Multisystem Involvement
Galapagos NV

Terminated

A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome (pSS) (GLIDER)

Primary Sjögren Syndrome

Germany, Greece, Poland, Hungary, Ukraine
Göteborg University

Completed

A Study of Flt3-Ligand Levels in Sjögrens Syndrome

Sjogrens Syndrome

Sweden
Federal University of São Paulo

Completed

Laser Therapy to Treat the Dry Mouth of Sjogren's Syndrome

XEROSTOMIA | KERATOCONJUNCTIVITIS SICCA | SICCA SYNDROME | PRIMARY SJOGREN SYNDROME

Brazil
Novartis Pharmaceuticals

Terminated

A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's Syndrome (LOUiSSe)

Sjögren Syndrome

Spain, United States, Belgium, Hungary, Germany, Switzerland, Australia, Denmark, China, Taiwan, United Kingdom, Bulgaria
Ankara Education and Research Hospital

Completed

Effects of Primary Sjögren's Syndrome on Female Genitalia and Sexual Functions

Primary Sjögren Syndrome

Turkey
University Hospital, Brest

Unknown

Eye Dryness Evaluation in Primary Sjögren's Syndrome (PEPSS)

Primary Sjögren Syndrome
Federal University of São Paulo

Completed

Resistance Exercise in Woman With Primary Sjörgen Syndrome.

Primary Sjögren Syndrome
Charite University, Berlin, Germany

Completed

Low Dose Cyclosporin A in Primary Sjögren Syndrome (CYPRESS)

Sjögren´s Syndrome

Germany
Peking Union Medical College Hospital

Not yet recruiting

68Ga-P16-093 PET/CT Imaging in the Salivary Gland

Primary Sjögren Syndrome
University of Sao Paulo General Hospital

Completed

Treatment of Dry Eye Using 0.03% Tacrolimus Eye Drops

Dry Eye Syndrome | Sjogren Syndrome

Brazil
University Hospital, Brest

Unknown

Inflammatory Myopathies in Primary Sjögren's Syndrome (AMISS)

Primary Sjögren Syndrome

France
Universidad Nacional de Colombia

Completed

Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry Eye

Dry Eye | Sjogren Syndrome
Helse Stavanger HF
University of Oslo; University of Stavanger

Completed

Fatigue and Interleukin-1 (IL-1) Blockade in Primary Sjøgrens Syndrome

Fatigue | Primary Sjogren

Norway
Hospital Nacional Profesor Alejandro Posadas

Completed

Amniotic Membrane Treatment for Hyposecretory Dry Eye

Dry Eye Syndromes | Sjogren Syndrome With Keratoconjunctivitis

Argentina
University Hospital, Clermont-Ferrand

Unknown

Echo Systemic Sclerosis

Systemic Sclerosis | Gougerot Sjogren Syndrome | Sicca-Asthenia-Polyalgia Syndrome

France
Peking Union Medical College Hospital

Not yet recruiting

Tacrolimus Plus Glucocorticoid for Severe Thrombocytopenia in SS

Sjogren Syndrome With Other Organ Involvement
Peking Union Medical College Hospital

Not yet recruiting

Tacrolimus for Thrombocytopenia in SS

Sjogren Syndrome With Other Organ Involvement
Pavly Moawd

Completed

Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren Syndrome

Dry Eye | Sjogren Syndrome

Egypt
Novartis Pharmaceuticals

Not yet recruiting

Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Disease

Rheumatoid Arthritis | Systemic Lupus Erythematosus | Sjögrens Disease
Santen Pharmaceutical(China) Co.,LTD

Completed

A Randomized, Parallel-Group Comparison Study of Topical Corticosteroids in Dry Eye Patients With Sjögren Syndrome

Dry Eye Syndromes | Sjögren Syndrome

China
Hospital Nacional Profesor Alejandro Posadas

Completed

Comparison Between Rebamipide 2% Versus Autologous Serum

Dry Eye Syndromes | Sjögren Syndrome

Argentina
Marmara University

Completed

Cutaneous Silent Period Assessment in Primary Sjögren's Syndrome

Small Fiber Neuropathy | Primary Sjögren Syndrome

Turkey
Unither Pharmaceuticals, France

Completed

A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA Study (NIAGARA)

Head and Neck Cancer | Xerostomia | Hyposalivation | Sjögren Syndrome

France
Bristol-Myers Squibb

Completed

A Study to Assess the Efficacy and Safety of Abatacept in Adults With Active Primary Sjögrens Syndrome

Sjogrens Disease

United States, France, Italy, Sweden, Japan, Australia, Mexico, Argentina, Brazil, Korea, Republic of, Czechia, Puerto Rico, Germany
NHS Greater Glasgow and Clyde
Glasgow Caledonian University; Lamellar Biomedical Ltd; Robertson Centre for...

Unknown

LAMELLEYE for the Treatment of Dry Eye Symptoms in pSS Patients

Dry Eye Syndromes | Primary Sjögren Syndrome
TearSolutions, Inc.

Completed

Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome

Dry Eye | Primary Sjögren Syndrome

United States

Clinical Trials on Marinesco-Sjogren Syndrome

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations